Hikma Pharmaceuticals
HIK.L
#2543
Rank
NZ$9.78 B
Marketcap
$44.11
Share price
0.05%
Change (1 day)
22.44%
Change (1 year)

P/S ratio for Hikma Pharmaceuticals (HIK.L)

P/S ratio at the end of 2023: 1.76

According to Hikma Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.51. At the end of 2023 the company had a P/S ratio of 1.76.

P/S ratio history for Hikma Pharmaceuticals from 2006 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20231.768.28%
20221.62-49.82%
20213.24-13.54%
20203.7411.6%
20193.3619.05%
20182.8232.14%
20172.13-35.88%
20163.33-48.17%
20156.4221.76%
20145.2753.56%
20133.4328.54%
20122.6710.12%
20112.42-35.58%
20103.7631.97%
20092.8573.09%
20081.65-64.97%
20074.70-13.94%
20065.47